PaxMedica, Inc. Common Stock
Cash Flow

Last updated:

Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of PaxMedica, Inc. Common Stock generated cash of -$10,768,504, which is less than the previous year. Cash used in financing activities reached the amount of $13,577,259 last year. Net change in cash is therefore $2,808,755.

Cash Flow

PaxMedica, Inc. Common Stock (NASDAQ:PXMD): Cash Flow
2019 -419.37K 0 435K
2020 -2.34M 0 3.44M
2021 -5.51M 0 4.83M
2022 -6.07M 0 7.52M
2023 -10.76M 0 13.57M

PXMD Cash Flow Statement (2019 โ€“ 2023)

2023 2022 2021 2020 2019
Cash at beginning of period
1.90M444.08K1.12M24.94K9.32K
Operating activities
Net income
-18.28M-14.80M-10.22M-7.82M-598.60K
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation and amortization
00000
Stock-based compensation expense
5.20M4.41M1.33M2.26M0
Deferred income tax benefit 5.20M4.41M1.33M2.26M0
Changes in operating assets and liabilities:
Accounts receivable, net
00000
Inventories
00000
Accounts payable
456.22K114.16K250.22K392.54K53.89K
Cash generated by operating activities
-10.76M-6.07M-5.51M-2.34M-419.37K
Investing activities
Purchases Of Investments
00000
Investments In Property Plant And Equipment
00000
Acquisitions Net
00000
Cash generated by investing activities
00000
Financing activities
Common Stock Issued
-503.69M6.02M5M00
Payments for dividends
00000
Repurchases of common stock
-195.99K-35K000
Repayments of term debt
2.45M1.24M0-2.92M0
Cash used in financing activities
13.57M7.52M4.83M3.44M435K
Net Change In Cash
2.80M1.45M-679.53K1.09M15.62K
Cash at end of period
4.71M1.90M444.08K1.12M24.94K
Data sourceData source